Dr.L.C.Yang is the Chief Executive Officer of Clone-E Therapeutics, Inc. which operates the Gene therapy laboratory, proteins or DNA microarray division and biotech related investments.
Monthly Archives: April 2010
Apr
12
2010
Hydroxyapatite for Biomolecule Purification
With Development Pathways Determined, HA Has Become a Mainstream Industrial Staple, Use Nanoshel Hydroxy Appatite (HA) available with Nanoshel
Apr
03
2010
NANOBIOTECHNOLOGY - DRUG DELIVERY AND TISSUE ENGINEERING
Controlled drug-delivery strategies have made a dramatic impact in medicine. In general, controlled-release polymer systems deliver drugs in the optimum dosage for long periods, thus increasing the efficacy of the drug, maximizing patient compliance and enhancing the ability to use highly toxic, poorly soluble or relatively unstable drugs.